Aptevo Therapeutics (APVO) Q2 2025 Earnings

May 15Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-87.8
-59.09
-30.38
-1.67

Details

Expected EPS
-84.2
Actual EPS
-87.8
Surprise EPS
-3.6
Surprise Percent
-4.28%

Description

⁨Aptevo Therapeutics⁩ (⁦APVO⁩) has reported earnings of ⁦-87.8⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts